Şunu aradınız:: methadone (Maltaca - İngilizce)

methadone
methadone

r- methadone
↓ 15%

methadone methadone
immunosuppressants

methadone/lamivudine
recommendation concerning co-administration

methadone auc ↓ 19%
careful therapeutic drug monitoring is necessary for immunosuppressants when co-administered with invirase/ ritonavir.

methadone u trizivir
methadone and trizivir

terapija b’ methadone.
patient’ s clinical response to methadone therapy.

auc ta’ methadone ↓47
methadone auc ↓47%

(r-) methadone: cmax 
(r-) methadone: cmax 

auc u cmin methadone: 
methadone auc and cmin: 

fid-doża ta’ methadone meta
when initiating co-administration of telaprevir.

- methadone, rifampicin, probenecid.
- methadone, rifampicin, probenecid.

indinavir u methadone jistgħu
indinavir and methadone

methadone, buprenorphine u naloxone
methadone, buprenorphine and naloxone

21% (r-) methadone: auc 
21% (r-) methadone: auc 

methadone (80-120 mg darba
methadone (80-120 mg once daily)

methadone (sostratt ta 'cyp3a4):
methadone (cyp3a4 substrate):

analġeżiċi narkotiċi methadone auc ↓ 19%
medicinal product by therapeutic area (dose of invirase used in study)

methadone cmax  0.58 (0.50 - 0.67)
methadone cmax ↓ 0.58 (0.50 - 0.67)

dożi individwali ta’ methadone lil pazjenti
methadone individual patient dosing